Seqens creates value in bringing its expertise and proficiency in biology and chemistry tools for developing innovative and competitive bioprocesses to manufacture…

With 6 cGMP/ FDA inspected plants in Europe and the United States for commercial production supported by two pre-GMP (ISO 9001) sites…

As a fully integrated CMO, SEQENS is uniquely positioned to supply an entire suite of development, analytical and cGMP manufacturing services for…

Seqens’ Newburyport facility produces bulk active pharmaceutical ingredients, New Chemical Entities (NCE’s) for clinical supply, and other custom manufactured products for the life science industry.

Seqens provides easy scale-up of volume from several kilograms to multi-ton.

Seqens operates an R&D facility in Devens, MA, and a manufacturing facility in Newburyport, MA, both of which are located in Boston’s booming biotechnology and pharmaceutical hub.

Seqens is a world leader in pharmaceutical synthesis, capable of providing development and production services at all stages of an active ingredient’s life cycle from the initial clinical stage to the generic stage in total compliance with the strictest quality, safety and environmental standards.